Novanta NOVT Medical Solutions — Segment Operating Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novanta in its filing.
Tagged under the XBRL concept novt:SegmentOperatingIncome.
The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novanta's medical solutions — segment operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Novanta's medical solutions — segment operating income?
- Novanta (NOVT) reported medical solutions — segment operating income of $16.73M in Q1 2026.
- How has Novanta's medical solutions — segment operating income changed year-over-year?
- Novanta's medical solutions — segment operating income increased by 19.2% year-over-year, from $14.03M to $16.73M.
- What is the long-term trend for Novanta's medical solutions — segment operating income?
- Over 3 years (2022 to 2025), Novanta's medical solutions — segment operating income has grown at a 3.0% compound annual growth rate (CAGR), from $46.87M to $51.17M.
- What does medical solutions — segment operating income mean?
- This is the primary measure of profitability for the business segment, calculated as revenue minus operating expenses, excluding interest and taxes. It serves as a key indicator of the segment's ability to generate profit from its core business activities. Investors use this to assess the operational efficiency and competitive strength of the specific business unit.